Turnstone Biologics logo

Turnstone Biologics

Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.

2

Funding Rounds

$121.4m

Money raised

Overview

Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.

Funding

Funding series

Funding Series Analysis

The company Turnstone Biologics has raised a total of $121.4m in funding over 2 rounds.

Key Insights:

  • Turnstone Biologics Series D round: $80m
  • Turnstone Biologics Series B round, November 2016: $41.4m
Turnstone Biologics logo
Turnstone Biologics Series D round $80m
Turnstone Biologics logo
Turnstone Biologics Series B round, November 2016 $41.4m